After sharing his story of a missed diagnosis and family silence, Gregory Jacob Jr.'s advocacy journey takes him from the ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate cancer in ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

AWARENESS MONTH, AND ACCORDING TO THE AMERICAN CANCER SOCIETY, THE DISEASE SEES OVER 300,000 NEW CASES YEARLY, AS WELL AS MORE THAN 35,000 DEATHS A YEAR, MAKING IT CRUCIAL FOR MEN TO UNDERGO A ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled ‘A Phase 3, Randomized, ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...